Between You And Me: FDA Comments Not Disclosure Events
In an important ruling dismissing a comprehensive securities class action complaint against Genzyme Corp., the U.S. District Court for the District of Massachusetts held last week that regulatory comments and inspectional...To view the full article, register now.
Already a subscriber? Click here to view full article